Elanco Animal Health Incorporat (ELAN) Stock Analysis
Breakout setup
Healthcare · Drug Manufacturers - Specialty & Generic
Sell if holding. At $24.17, A.R:R 0.5:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 7.2%; Weak overall score: 4.9/10.
Elanco Animal Health is a global animal health company offering pet health and farm animal products sold in more than 90 countries, with the U.S. accounting for 47% of total revenue. Revenue is generated through veterinary distributors, retailers and farm animal producers; the... Read more
Sell if holding. At $24.17, A.R:R 0.5:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 7.2%; Weak overall score: 4.9/10. Chart setup: Golden cross, above all MAs, RSI 64, MACD bullish. Score 4.9/10, moderate confidence.
Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 53d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated 2026-06-14Recent Developments — Elanco Animal Health Incorporat
Latest news
- NEWS Analysts estimate Elanco Animal Health Incorporated (ELAN) to report a decline in earnings: What to look out for - MSN — MSN neutral
- NEWS Analysts Estimate Elanco Animal Health Incorporated (ELAN) to Report a Decline in Earnings: What to Look Out for - Yahoo — Yahoo Finance negative
- NEWS Elanco Animal Health (ELAN) Receives a Buy from Bank of America Securities - The Globe and Mail — The Globe and Mail positive
- NEWS Elanco Animal Health (ELAN) to Release Quarterly Earnings on Wednesday - MarketBeat — MarketBeat neutral
- NEWS Elanco Animal Health Incorporated (ELAN) beats Q1 earnings and revenue estimates - MSN — MSN positive
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. At $24.17, A.R:R 0.5:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Thin upside margin: 7.2%; Weak overall score: 4.9/10. Chart setup: Golden cross, above all MAs, RSI 64, MACD bullish. Prior stop was $22.48. Score 4.9/10, moderate confidence.
Take-profit target: $25.91 (+7.2% upside). Prior stop was $22.48. Stop-loss: $22.48.
Thin upside margin: 7.2%; Weak overall score: 4.9/10; Weak growth.
Elanco Animal Health Incorporat trades at a P/E of N/A (forward 20.4). TrendMatrix value score: 5.2/10. Verdict: Sell.
22 analysts cover ELAN with a consensus score of 4.3/5. Average price target: $30.
What does Elanco Animal Health Incorporat do?Elanco Animal Health is a global animal health company offering pet health and farm animal products sold in more than...
Elanco Animal Health is a global animal health company offering pet health and farm animal products sold in more than 90 countries, with the U.S. accounting for 47% of total revenue. Revenue is generated through veterinary distributors, retailers and farm animal producers; the top 5 product families represent approximately 38% of revenue.